Clinical Trial Update: Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) in Migraine Headaches [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update reports efficacy and safety results for botulinum toxin A (Botox) in refractory migraine, across Phase 2 and Phase 3 studies, with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Yale University | Conditions: Refractory Migraine | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2016-03-14